Is mucin1 same as myxoprotein 1?
Best insight from top research papers
Mucin1 and myxoprotein 1 are not the same. Mucin1 is a transmembrane protein that is overexpressed in breast and other cancers. It has a role in regulating the expression and localization of the tumor-associated protein MUC1 . MUC1 is a membrane-binding mucoprotein that is widely distributed on the surface of tumor cells and is an important tumor marker . On the other hand, myxoprotein 1 is not mentioned in any of the provided abstracts. Therefore, there is no evidence to suggest that mucin1 and myxoprotein 1 are the same protein.
Answers from top 5 papers
More filters
Papers (5) | Insight |
---|---|
The paper does not mention anything about myxoprotein 1. The paper discusses the localization and distribution patterns of MUC1, a transmembrane member of the mucin family, in breast carcinoma cells. | |
The paper does not mention anything about "myxoprotein 1". | |
The paper does not mention anything about "myxoprotein 1". | |
Patent 19 Jun 2013 6 Citations | The provided paper does not mention anything about myxoprotein 1. |
The provided paper does not mention anything about myxoprotein 1. |
Related Questions
What is the function of YTHDF1?6 answersYTHDF1, an N6-methyladenosine (m6A) reader protein, plays a multifaceted role in various biological processes and diseases, particularly in cancer and asthma. In bladder cancer, YTHDF1, in conjunction with METTL3, influences cell proliferation and cisplatin sensitivity through the regulation of the METTL3/YTHDF1–RPN2–PI3K/AKT/mTOR axis, indicating its involvement in tumor progression and therapeutic response. Similarly, in breast cancer, YTHDF1 contributes to the establishment of a "cold" tumor microenvironment by inhibiting pro-inflammatory cytokine release from cancer cells, thereby reducing the infiltration and functional differentiation of anti-tumor CD8+ T cells and facilitating immune evasion.
In acute myelogenous leukemia (AML), YTHDF1 is overexpressed, particularly in leukemia stem cells, and its depletion attenuates leukemic capacity, suggesting its role in AML progression through the regulation of cyclin E2 translation in an m6A-dependent manner. In gastric cancer, YTHDF1's overexpression is associated with aggressive tumor progression and poor survival, where it promotes the translation of the Wnt receptor FZD7, enhancing Wnt/β-catenin signaling and carcinogenesis. This regulatory mechanism of YTHDF1 on the Wnt/β-catenin pathway is further supported by its role in regulating downstream players of this pathway.
Moreover, YTHDF1's involvement extends to DNA repair and cancer immunity, where its overexpression in gastric cancer enhances DNA damage repair and modulates gene expression in protein levels, affecting cancer immunity. In the context of asthma, YTHDF1 has been found to upregulate in airway smooth muscle cells, promoting their proliferation and migration through the stabilization of cyclin D1 mRNA in an m6A-dependent manner, highlighting its role in airway remodeling.
In summary, YTHDF1 functions as a critical regulator in various cancers by influencing tumor progression, immune evasion, and DNA repair, as well as playing a significant role in asthma pathogenesis through airway remodeling.
What component in mucin does PA FliD bind with?5 answersPA FliD, a protein of Pseudomonas aeruginosa, binds to mucin, specifically interacting with the carbohydrate chains present on mucins. The binding of P. aeruginosa to mucins involves outer membrane proteins and mucin carbohydrate chains that are structurally different from the carbohydrate recognized by pillin. Additionally, the flagellar cap protein FliD participates in the adhesion process of P. aeruginosa to mucin, as demonstrated by in vitro assays and competition experiments. This interaction between PA FliD and mucin is crucial for the initial colonization of P. aeruginosa in the airways of cystic fibrosis patients. The unique regulation of the fliD gene in P. aeruginosa further supports its involvement in mucin adhesion, independent of the flagellar sigma factor sigma28.
Do mucin in urethra involved in infection defense?5 answersMucins in the urethra play a crucial role in the defense against infections. These glycoproteins form a protective barrier that decreases bacterial adherence to the bladder mucosa, reducing the likelihood of infection establishment. Additionally, mucins are part of the innate immune system and aid in the clearance of pathogens from epithelial barriers. The urogenital tract, including the urethra, lacks physical barriers like multi-layered mucus, making mucins essential for defense against potentially harmful microorganisms. Mucins are involved in protecting epithelial cells from infection and injury, highlighting their significance in maintaining mucosal integrity and preventing infections in the urogenital tract. Therefore, mucins in the urethra are integral components of the body's defense mechanisms against infections.
Where is muc20 expressed?4 answersMUC20 is expressed in different cell types of the human endometrium, specifically in the epithelial cells of the receptive endometrium. MUC20 is also expressed at the ocular surface. In addition, MUC20 is expressed in gastric cancer cells, particularly in signet ring cell carcinoma (SRCC). Furthermore, MUC20 expression has been observed in clear cell renal cell carcinoma (ccRCC) specimens, where it is positively correlated with survival and negatively correlated with clinicopathologic characteristics. MUC20 expression has also been studied in esophageal squamous cell carcinoma (ESCC), where it is mainly expressed in the cytoplasm.
Which cells produce MUC2 mucin?4 answersGoblet cells are the cells that produce MUC2 mucin.
Does HER3 interact with MUC1?3 answersHER3 interacts with MUC1 in bladder cancer patients, and this interaction is associated with a favorable prognosis. The functional impact of the interaction between MUC1 and HER3 was investigated in bladder cancer patients, and it was found that high expression of MUC1 along with high expression of HER3 was associated with a favorable survival outcome. However, when MUC1 expression was low, the co-expression of HER3 did not influence the prognostic value of MUC1. This suggests that HER3 is involved in the function of MUC1 in bladder cancer.